Editorial Policy

The Peptide Review is built to be a trustworthy, evidence-first source. This policy explains how we research, write,

and maintain our content.

Sourcing

Every claim of fact is tied to a primary source — a peer-reviewed study, a systematic review, a regulatory

document, or an official database (such as PubMed, PubChem, or ClinicalTrials.gov). Where possible, we link

directly to the original work so readers can verify it themselves.

Levels of evidence

Not all findings carry the same weight. We label evidence so readers know how much confidence to place in a

statement:

Established — supported by multiple independent studies or strong consensus reviews.

Preliminary — early findings from a limited number of studies, often in vitro or in animal models, not

yet confirmed in humans.

Unverified / anecdotal — claims that circulate widely but lack published support. We identify these as

such rather than repeating them as fact.

What we do not do

We do not provide medical advice, diagnoses, dosing, or protocols.

We do not make therapeutic, health, or performance claims.

We do not recommend or endorse specific vendors or products.

Research context

Many compounds we discuss are studied in laboratory and preclinical settings and are not approved for human or

veterinary use. We describe them in that research context only.

Accuracy and updates

Articles carry a "last reviewed" date. As the literature evolves, we revise older articles and note significant

changes. If you spot an error, tell us — we correct promptly and transparently.

CorrectionsTo report a correction, email us with the article title and the specific issue. Verified corrections are made to the

article, and material correcttons are noted at the bottom of the piece.

Last updated: 08/06/2026